Securities code: 688575 securities abbreviation: Shenzhen Yhlo Biotech Co.Ltd(688575) Announcement No.: 2022-019 Shenzhen Yhlo Biotech Co.Ltd(688575)
Announcement on the resolution of the fifth meeting of the third board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
Shenzhen Yhlo Biotech Co.Ltd(688575) (hereinafter referred to as “the company”) the fifth meeting of the third board of supervisors (hereinafter referred to as “the meeting”) was held in an on-site manner on February 7, 2022. There were 3 supervisors who should attend the meeting, and 3 supervisors actually attended, accounting for 100% of the number of supervisors who should attend. The convening and convening procedures of this meeting meet the requirements of the articles of association and relevant laws and regulations. After deliberation and voting by the supervisors present at the meeting, the following resolutions were reached at the meeting:
1、 The proposal on adjusting the incentive plan for restricted stocks in 2022 was deliberated and adopted
The company’s adjustment of the list of incentive objects and the number of rights and interests granted for the first time in the 2022 restricted stock incentive plan complies with the provisions of relevant laws and regulations such as the administrative measures for equity incentive of listed companies (hereinafter referred to as the “administrative measures”) and the 2022 restricted stock incentive plan (Draft) (hereinafter referred to as the “incentive plan (Draft)” ）According to the relevant provisions of the company, there is no situation that damages the interests of shareholders of the company; The adjusted incentive objects meet the conditions as incentive objects specified in relevant laws and regulations, and the subject qualification is legal and effective. It is agreed that the company will adjust the list of incentive objects and the number of rights and interests granted for the first time in the 2022 restricted stock incentive plan.
For details, please refer to the website of Shanghai Stock Exchange on the same day（ http://www.sse.com.cn. ）Announcement of Shenzhen Yhlo Biotech Co.Ltd(688575) on matters related to the adjustment of the restricted stock incentive plan in 2022 (Announcement No.: 2022-016) disclosed on the.
Voting result: 3 votes in favor; 0 votes against; There were no abstentions.
2、 The proposal on granting restricted shares to incentive objects for the first time was deliberated and adopted
The company is not prohibited to implement the equity incentive plan as stipulated in the management measures and other laws, regulations and normative documents, and the company has the subject qualification to implement the equity incentive plan; The incentive objects of this incentive plan have the qualifications specified in the company law of the people’s Republic of China and other laws, regulations and normative documents, meet the conditions of incentive objects specified in the administrative measures and the Listing Rules of science and Innovation Board of Shanghai Stock Exchange, and meet the scope of incentive objects specified in the incentive plan (Draft) and its summary, Its subject qualification as the incentive object of the company’s restricted stock incentive plan in 2022 is legal and effective.
The company determines that the first grant date of the incentive plan complies with the relevant provisions on the grant date in the administrative measures and the incentive plan (Draft) and its abstract.
Therefore, the board of supervisors agreed that the first grant date of the company’s incentive plan was February 7, 2022, and granted 1633000 restricted shares to 63 eligible incentive objects at the grant price of 16.00 yuan / share.
For details, please refer to the website of Shanghai Stock Exchange on the same day（ http://www.sse.com.cn. ）Announcement of Shenzhen Yhlo Biotech Co.Ltd(688575) on granting restricted shares to incentive objects for the first time (Announcement No.: 2022-017) disclosed on the.
Voting result: 3 votes in favor; 0 votes against; There were no abstentions.
It is hereby announced.
Shenzhen Yhlo Biotech Co.Ltd(688575) board of supervisors February 8, 2022
